{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:28:55Z","timestamp":1783434535764,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1245\/s10434-015-4548-6","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T14:30:52Z","timestamp":1428935452000},"page":"4224-4232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis"],"prefix":"10.1245","volume":"22","author":[{"given":"Sofiane","family":"Bendifallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Canlorbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enora","family":"Laas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Graesslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Raimond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Collinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Bleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"4548_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60: 277\u2013300.","journal-title":"CA Cancer J Clin."},{"key":"4548_CR2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cncr.27405","volume":"118","author":"L Zhu","year":"2012","unstructured":"Zhu L, Pickle LW, Ghosh K, et al. Predicting US- and state-level cancer counts for the current calendar year: part II: evaluation of spatiotemporal projection methods for incidence. Cancer. 2012;118:1100\u20139.","journal-title":"Cancer."},{"issue":"Suppl 6","key":"4548_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/annonc\/mdt353","volume":"24","author":"N Colombo","year":"2013","unstructured":"Colombo N, Preti E, Landoni F. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2013;24(Suppl 6):33\u20138.","journal-title":"Ann Oncol."},{"key":"4548_CR4","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"PB Panici","year":"2008","unstructured":"Panici P, Basile S, Maneschi F. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707\u201316.","journal-title":"J Natl Cancer Inst."},{"key":"4548_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(09)60678-4","volume":"373","author":"H Kitchener","year":"2009","unstructured":"ASTEC study group, Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125\u201336.","journal-title":"Lancet."},{"key":"4548_CR6","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404\u201311.","journal-title":"Lancet."},{"key":"4548_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","volume":"24","author":"ME Randall","year":"2006","unstructured":"Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2006;24:36\u201344.","journal-title":"J Clin"},{"key":"4548_CR8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","volume":"375","author":"Y Todo","year":"2010","unstructured":"Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165\u201372.","journal-title":"Lancet."},{"key":"4548_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2011.11.049","volume":"125","author":"EK Nugent","year":"2012","unstructured":"Nugent EK, Bishop EA, Mathews CA, et al. Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? Gynecol Oncol. 2012;125:94\u20138.","journal-title":"Gynecol Oncol."},{"key":"4548_CR10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1470-2045(11)70070-5","volume":"12","author":"M Ballester","year":"2011","unstructured":"Ballester M, Dubernard G, L\u00e9curu F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469\u201376.","journal-title":"Lancet Oncol."},{"key":"4548_CR11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364\u201370.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"4548_CR12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/suro.2002.32936","volume":"20","author":"JA Eastham","year":"2002","unstructured":"Eastham JA, Kattan MW, Scardino PT. Nomograms as predictive models. Semin Urol Oncol. 2002;20:108\u201315.","journal-title":"Semin Urol Oncol."},{"key":"4548_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygyno.2013.06.037","volume":"131","author":"MM AlHilli","year":"2013","unstructured":"AlHilli MM, Podratz KC, Dowdy SC, et al. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol. 2013;131:103\u20138.","journal-title":"Gynecol Oncol."},{"key":"4548_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ajog.2012.06.080","volume":"207","author":"S Bendifallah","year":"2012","unstructured":"Bendifallah S, Genin AS, Naoura I, et al. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol. 2012;207:197\u2013e1.","journal-title":"Am J Obstet Gynecol."},{"key":"4548_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol. 2009;105:103\u20134.","journal-title":"Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet."},{"key":"4548_CR16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2012.10.009","volume":"128","author":"MM AlHilli","year":"2013","unstructured":"AlHilli MM, Podratz KC, Dowdy SC, et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013;128:294\u20139.","journal-title":"Gynecol Oncol."},{"key":"4548_CR17","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/annonc\/mdm334","volume":"18","author":"Y Delpech","year":"2007","unstructured":"Delpech Y, Cortez A, Coutant C, et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol. 2007;18:1799\u2013803.","journal-title":"Ann Oncol"},{"key":"4548_CR18","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/sim.6107","volume":"33","author":"R He","year":"2014","unstructured":"He R, Belin T. Multiple imputation for high-dimensional mixed incomplete continuous and binary data. Stat Med. 2014;33:2251\u201362.","journal-title":"Stat Med."},{"key":"4548_CR19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3758\/BF03206482","volume":"11","author":"E-J Wagenmakers","year":"2004","unstructured":"Wagenmakers E-J, Farrell S. AIC model selection using Akaike weights. Psychon Bull Rev. 2004;11:192\u20136.","journal-title":"Psychon Bull Rev."},{"key":"4548_CR20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med."},{"key":"4548_CR21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0","volume":"19","author":"EW Steyerberg","year":"2000","unstructured":"Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19:1059\u201379.","journal-title":"Stat Med."},{"key":"4548_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29\u201336.","journal-title":"Radiology."},{"key":"4548_CR23","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","volume":"27","author":"C Coutant","year":"2009","unstructured":"Coutant C, Olivier C, Lambaudie E, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol. 2009;27:2800\u20138.","journal-title":"J Clin Oncol"},{"key":"4548_CR24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/sim.4780100805","volume":"10","author":"ME Miller","year":"1991","unstructured":"Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat Med. 1991;10:1213\u201326.","journal-title":"Stat Med."},{"key":"4548_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","volume":"16","author":"EF Schisterman","year":"2005","unstructured":"Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiol Camb Mass. 2005;16:73\u201381.","journal-title":"Epidemiol Camb Mass."},{"key":"4548_CR26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0090-8258(90)90166-I","volume":"36","author":"CP Morrow","year":"1990","unstructured":"Morrow CP, Bundy BN, Homesley HD, et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. Gynecol Oncol. 1990;36:166\u201371.","journal-title":"Gynecol Oncol."},{"key":"4548_CR27","first-page":"63","volume":"78","author":"JR Lurain","year":"1991","unstructured":"Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 1991;78:63\u20139.","journal-title":"Obstet Gynecol."},{"key":"4548_CR28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744\u201351.","journal-title":"Gynecol Oncol."},{"key":"4548_CR29","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1200\/JCO.2009.22.3248","volume":"27","author":"JL Walker","year":"2009","unstructured":"Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:5331\u20136.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"4548_CR30","author":"S Bendifallah","year":"2014","unstructured":"Bendifallah S, Canlorbe G, Raimond E, et al. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. Br J Cancer. 2014. doi: 10.1038\/bjc.2014.237 .","journal-title":"Br J Cancer."},{"key":"4548_CR31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jamcollsurg.2004.05.258","volume":"199","author":"M Frumovitz","year":"2004","unstructured":"Frumovitz M, Slomovitz BM, Singh DK, et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004;199:388\u201393.","journal-title":"J Am Coll Surg."},{"key":"4548_CR32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2013.01.020","volume":"129","author":"EM Ko","year":"2013","unstructured":"Ko EM, Funk MJ, Clark LH, Brewster WR. Did GOG99 and PORTEC1 change clinical practice in the United States? Gynecol Oncol. 2013;129:12\u20137.","journal-title":"Gynecol Oncol."},{"key":"4548_CR33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.6004\/jnccn.2009.0035","volume":"7","author":"BE Greer","year":"2009","unstructured":"Greer BE, Koh WJ, AbuRustum N. Uterine neoplasms Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw JNCCN. 2009;7:498\u2013531.","journal-title":"J Natl Compr Cancer Netw JNCCN."},{"key":"4548_CR34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00042307-200303000-00005","volume":"13","author":"MW Kattan","year":"2003","unstructured":"Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13:111\u20136.","journal-title":"Curr Opin Urol."},{"key":"4548_CR35","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1245\/s10434-012-2390-7","volume":"19","author":"M Ballester","year":"2012","unstructured":"Ballester M, Dubernard G, Bats A-S, et al. Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study. Ann Surg Oncol. 2012;19:3515\u201321.","journal-title":"Ann Surg Oncol."},{"key":"4548_CR36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92\u2013105.","journal-title":"Biometrics."},{"key":"4548_CR37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ygyno.2006.10.002","volume":"104","author":"Y Todo","year":"2007","unstructured":"Todo Y, Okamoto K, Hayashi M, et al. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy. Gynecol Oncol. 2007;104:623\u20138.","journal-title":"Gynecol Oncol."},{"key":"4548_CR38","author":"S Bendifallah","year":"2014","unstructured":"Bendifallah S, Canlorbe G, Raimond E, et al. External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study. Am J Obstet Gynecol. 2014. doi: 10.1016\/j.ajog.2014.06.058 .","journal-title":"Am J Obstet Gynecol."},{"key":"4548_CR39","author":"E Raimond","year":"2014","unstructured":"Raimond E, Ballester M, Hudry D, et al. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol. 2014. doi: 10.1016\/j.ygyno.2014.03.019 .","journal-title":"Gynecol Oncol."},{"key":"4548_CR40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/aje\/kwn071","volume":"168","author":"MA Klebanoff","year":"2008","unstructured":"Klebanoff MA, Cole SR. Use of multiple imputation in the epidemiologic literature. Am J Epidemiol. 2008;168:355\u20137.","journal-title":"Am J Epidemiol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4548-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4548-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:24:41Z","timestamp":1559633081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4548-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4548"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4548-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]}}}